• Opioidology Part 3: Opioid-Philia vs Opioid-Phobia | Pain Pod
    Jan 12 2026

    Opioidology Part 3: Opioid-Philia vs Opioid-Phobia The often-blurred lines of pain, addiction, and substance use need a deeper dive into the extremes of opioid-philia and opioid-phobia (building upon Opioidology Part 1: Our Opioid Story). Join Mark “Pain Guy” Garofoli and our two guests James Hackworth and Jim Potenziano to take that deeper dive based on their recent collaboration in the Frontiers in Pain Research article “The Burden of Acute Pain in the U.S. in the Wake of the Opioid Crisis”. • Frontiers in Pain Research Article: https://www.frontiersin.org/journals/pain-research/articles/10.3389/fpain.2025.1642035/full • Article Key Takeaways • Rising Pain Prevalence • Balancing Act—Opioid Utilization vs. Undertreatment • Provider Reluctance to use opioids • Patient Reluctance • Massive Economic Impact • Call for Innovation & Policy Reform • Opioid Story charts: www.painguy.us

    Show More Show Less
    47 mins
  • The Three Biggest Healthcare News of 2025| RxRated Podcast
    Jan 12 2026

    In this episode of the Rated Rx Podcast, pharmacists break down the biggest healthcare news of 2025 and what it actually means for patients and clinicians 👀💊. You hear real pharmacist perspectives on artificial intelligence in healthcare, new federal plans to regulate AI, and why clinical judgment, patient trust, and human decision making still matter more than algorithms 🤖➡️🧠. The conversation also dives into major vaccine policy changes, including updates to newborn hepatitis B vaccination recommendations and why shifts like this raise real concerns for public health 🧬🩺. The crew explains what these changes mean in practice, how misinformation spreads fast, and why prevention still saves lives. Later, the episode tackles the explosion of GLP 1 weight loss medications like semaglutide and tirzepatide. You hear honest discussion about access, cost, compounding risks, and why obesity needs to be treated as a chronic disease instead of a personal failure ⚖️📈. This episode blends news, clinical insight, and real world experience to unpack where healthcare is heading next. This podcast is intended for entertainment and informational purposes only. Listen and Follow Rated Rx 🎙️ Apple Podcasts https://podcasts.apple.com/us/podcast/the-rated-rx-podcast/id1804181016 Spotify https://open.spotify.com/show/7KATtG1c3HwwYpVMtRuNub Facebook https://www.facebook.com/profile.php?id=61574813907982 Instagram https://www.instagram.com/ratedrxpodcast/ TikTok https://www.tiktok.com/@ratedrxpodcast

    Show More Show Less
    43 mins
  • The Season to Innovate: Strategic Legal and Regulatory Considerations for Approaching Acquisitions and Vetting AI Vendors | NASP Specialty Pharmacy Podcast
    Jan 9 2026
    In this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, speaks with Simone Colgan Dunlap, National Vice Chair of the Quarles Health and Life Sciences Practice Group, and Amy Cotton Peterson, Partner at Quarles. As more automation solutions become available, its vital specialty pharmacy providers strategically approach acquisition of targets that offer technology and AI assets. This discussion explores effective diligence practices, common pitfalls, and risk mitigation strategies for specialty pharmacies navigating mergers and acquisitions and the rapidly evolving use of artificial intelligence.
    Show More Show Less
    22 mins
  • Doing Things Differently: YARAL Pharma, Pennsylvania Policy, and the Birth Control Pharmacist | TWIRx
    Jan 9 2026
    🎙️ This Week in Pharmacy (TWIRx) — January 9, 2026 Welcome to TWIRx — This Week in Pharmacy! I’m your host Todd Eury, and today’s episode is sponsored by YARAL Pharma, a generics company committed to “Doing Things Differently”—with a human-centered, untraditional approach that’s redefining relationships between industry and pharmacy practice. ✅ Today’s Sponsor: YARAL Pharma YARAL Pharma is committed to innovation, partnership, and supporting pharmacists at the front lines—especially as healthcare continues to restructure and the role of the pharmacist becomes more essential than ever. Their mission to Do Things Differently is more than a slogan—it’s a commitment to reshaping what a generics company can stand for in today’s healthcare marketplace. 📰 This Week in Pharmacy — News 1) Amazon Pharmacy to Offer Novo Nordisk’s Wegovy Pill Nationwide Amazon Pharmacy is now offering Novo Nordisk’s newly FDA-approved Wegovy pill, making the weight-loss medication available nationwide through both insurance coverage and cash-pay options. This move continues Amazon’s expansion into digital healthcare access—bringing blockbuster GLP-1 therapies directly to consumers and increasing competition among major pharmacy providers. https://www.mobihealthnews.com/news/amazon-pharmacy-offer-novo-nordisks-wegovy-pill 2) Dr. David Pope: AI, Online Pharmacies, and Why the Neighborhood Pharmacist Still Wins Trust In a must-read guest column, Dr. David Pope argues that while AI and online pharmacy services are rapidly surging, the community pharmacist remains one of the most trusted healthcare professionals in America. He points to how pharmacy deserts, increasing reimbursement pressure, and policy reform will reshape pharmacy in 2026—and why the profession’s future will depend on protecting and empowering local pharmacy care. https://drugstorenews.com/ai-and-online-pharmacy-surge-neighborhood-pharmacist-remains-most-trusted 3) Pharmacist Leadership Spotlight: Illuminate Rx Names Ritu Malhotra, PharmD, as President Illuminate Rx announced the appointment of Ritu Malhotra, PharmD, as its new President, reinforcing the growing trend of pharmacists stepping into leadership roles across pharmacy benefits and PBM reform. With decades of experience modernizing healthcare and pharmacy benefit strategy, Malhotra’s appointment signals Illuminate Rx’s focus on improving transparency and clarity in pharmacy benefits management. https://www.prnewswire.com/news-releases/illuminate-rx-appoints-industry-veteran-ritu-malhotra-pharmd-as-president-to-advance-clarity-in-pharmacy-benefits-302657441.html 4) Viatris Exec David Marin Named New CEO of PCMA The Pharmaceutical Care Management Association (PCMA)—the leading PBM trade group—has named David Marin, previously Head of Global Government Affairs & Public Policy at Viatris, as its next President and CEO effective January 30, 2026. His selection comes at a pivotal time as PBMs face rising scrutiny and intensifying policy pressure nationwide. https://www.healthcaredive.com/news/pcma-names-new-ceo-david-marin/809158/ 🎤 Interviews & Segments ⭐ Segment 1 — Special Sponsor Interview Stephen Beckman, CEO of YARAL Pharma We kick off TWIRx with a special conversation featuring Stephen Beckman, CEO of YARAL Pharma, exploring what 2026 has in store for pharmacy and healthcare. We discuss the Pharmacy 50 Awards, the importance of honoring leadership across the profession, and why supporting pharmacists right now—during one of the most fragile and transformative moments in U.S. healthcare—is absolutely critical. ⭐ Featured Interview — Pennsylvania State Representative Rep. Charity Grimm Krupa — 51st Legislative District Today’s featured interview is with State Representative Charity Grimm Krupa, who represents Pennsylvania’s 51st Legislative District in the House of Representatives. We discuss real healthcare issues impacting Pennsylvanians—including medical cannabis, small business healthcare benefit strategies, and why it’s essential for healthcare professionals to stay connected with their state lawmakers. Rep. Krupa also shares why every citizen should aim to communicate with their own representatives at least once per year. ⭐ Segment 2 — Clinical & Policy Spotlight Dr. Sally Rafie, PharmD — “The Birth Control Pharmacist” In our second segment, we welcome Dr. Sally Rafie, PharmD, nationally known as the “Birth Control Pharmacist.” Dr. Rafie is a clinical pharmacist specialist at UC San Diego Health and an assistant clinical professor at the UC San Diego Skaggs School of Pharmacy, widely recognized for advancing pharmacists’ role in reproductive health care. She is also the founder of Birth Control Pharmacist, an education and training company that equips pharmacists and healthcare teams to prescribe and deliver contraception care through evidence-based ...
    Show More Show Less
    1 hr and 37 mins
  • The Peptide Problem | Essential: The Pharmacy Compounding Podcast
    Jan 8 2026

    In this edition of Essential, we’ve got concerns about the FDA’s revolving door, some issues with a new California law that might affects the whole country, and a new accreditation that might save a lot of headache. Then we take a deep dive into the once and future world of compounded peptides — where they are, and where they might be going … and why. Links FDA’s revolving door: https://archive.ph/oxBXP Join APC today: https://a4pc.org/membership Coalition for Compounding Excellence (CCE) accreditation: https://414uue.share-na2.hsforms.com/2n_hRAnRSQ4O8VteGTesF0Q?_hsenc=p2ANqtz-9rfyq3GuFFZw6omRa96tq_es549FWmjiw-sP5NU3LKrsL1eump-l18h7xVrvy8G_V1Pi4UFkfhARMnPCLIx7TBOwPClQ&_hsmi=394109070 Pharma Source Direct: https://www.linkedin.com/company/pharma-source-direct/

    Show More Show Less
    34 mins
  • From Counter to Clinic: Implementing Prescribing Services | Pharmacist-Prescribed
    Jan 7 2026
    In Episode 2 of Pharmacist-Prescribed, hosts Mary Kucek, PMP, Founder and CEO of OvaryIt, and Devin Bustin, MD, Chief Medical Officer of OvaryIt, dive into the practical realities of implementing pharmacist-led prescribing services in community pharmacy settings. The conversation explores how pharmacies can navigate state-specific prescribing authority, standing orders, collaborative practice agreements, staffing concerns, and day-to-day workflows without disrupting existing operations. Listeners will gain a clear picture of how the PRISM platform supports safe, compliant, and efficient clinical service delivery, from patient intake and documentation to e-prescribing and team-based care. Learn more about PRISM or request a demo at https://www.getprismrx.com
    Show More Show Less
    30 mins
  • Cleansing and Nourishing Rituals with Ayurvedic Oils with Osi Mizrahi | The Holistic Pharmacy Podcast
    Jan 6 2026

    I was truly inspired by today’s guest and her courage to follow her inner guidance, which served her not only on her personal journey but also led her to found a beautiful company with a sacred mission. Osi Mizrahi is the founder and visionary behind OSI Oils—a wellness brand rooted in slow beauty, Ayurvedic ritual, and the art of coming home to oneself. Born on a farm in Israel, Osi’s connection to the natural world began early, shaping her journey as a medical intuitive, Ayurvedic artisan, and guide in the healing arts. With over 30 years of experience in yoga, Ayurveda, Reiki, Kundalini, and Theta Healing, Osi blends ancient wisdom with feminine embodiment. Her work is inspired by Kabbalah, breathwork, and intuitive practices that support deep transformation. Osi believes in slow beauty and slow aging—practices that honor the body’s rhythms and nourish vitality over time. Oils, for her, are more than skincare—they are vessels of self-love, sensuality, and spiritual healing. Each OSI Oils formula is handcrafted in small batches using traditional Ayurvedic methods, turning everyday routines into sacred rituals. Whether soothing the nervous system with her belly oil or igniting life-force energy with Radiance Hair Oil, her products are designed to restore from the inside out. Osi’s upcoming book shares her own journey through heartbreak, healing, and the power of ancient rituals. Through her storytelling, mentorship, and botanical creations, she helps women around the world reconnect to their spark—and live with more pleasure, purpose, and presence. Connect with Osi via: Email: osi@osioils.com Website: Osi Oils IG: @osioils YT: @OsiMizrahi Linked In: Osi Mizrahi Use My Special Promo Code RAWFORK20 for 20% off orders on osioils.com Visit https://marinabuksov.com for more holistic content. Music from https://www.purple-planet.com. Disclaimer: Statements herein have not been evaluated by the Food and Drug Administration. Products listed are not intended to diagnose, treat, cure, or prevent any diseases.

    Show More Show Less
    56 mins
  • Embracing Pharmacy Evolution | Surecast Live Part 3
    Jan 5 2026
    This is SureCast -- 3-Part Series recorded LIVE from Nashville, where pharmacy leaders, innovators, and forward-thinking professionals gathered for SureCost Insights 2025: Embracing Pharmacy Evolution, held November 13–14, 2025.

    In this episode we hear from:

    Jessica Daley

    Josh Hart - OPTU Consulting

    Matt Gilbert - RxSafe

    Mike Salazzo - Capital Drug

    Paul Shelton - LTC@Home

    Show More Show Less
    34 mins